Abstract YO17
Case summary
Olfactory Neuroblastoma with Cervical Lymph Node Metastases in a 21- Year old Filipino Woman: A Case Report
Background
Olfactory Neuroblastoma (ONB) is a rare, malignant, neuroectodermal tumor arising from olfactory receptor cells high in the olfactory plate. Accounting only 2% of all sinonasal tract tumors, its clinicopathologic and immunohistochemical features can be difficult. It has a unimodal age distribution commonly in the 5th- 6th decades of life with a 5-year overall survival and cancer-specific survival rates of 69% and 78%. Cervical lymph node metastasis is variable with only few published reports. Lymphatic metastasis has shown to be a significant predictor of survival.
AIMS
To present a rare case ONB in a 21-year old woman presenting with proptosis and sudden onset blindness.
METHOD
Case Report
RESULT
We report the case of a 21-year old woman who presented with proptosis, sudden onset blindness and enlarged right cervical nodes. She was initially treated as a case of Hyperthyroidism with no improvement. The cervical neck mass biopsy revealed the mass to be consistent with ONB. Immunohistochemistry showed positive Synaptophysin and EMA and negative S-100 and CD-3. Cranial CT with intravenous contrast (CT-IVC) demonstrated a lobulated enhancing slightly hyperdense lesion 8 cm x 7.6 cm x 6.4 cm (lxwxap) in the nasoorbitosinofrontal area with destruction of the ethmoid, right orbitofrontal and sphenoidal walls, bilateral medial orbital walls, more in the right and dorsum sella. It extends from the right orbit and to the frontal and sellar areas. Neck CT-IVC showed right cervical mass of 3.5 cm x 3.7 cm x 5.6 cm, with multiple paracervical, prevertebral, and submandibular nodules. She underwent 4 cycles of chemotherapy with Cisplatin and Etoposide concurrent with 30 sessions of 50 Gy Linear Accelerator Radiotherapy. She showed a remarkable response with a 90% mass size reduction. The blindness, however, remains to be irreversible.
CONCLUSION
ONB rarely presents with ophthalmologic findings and cervical lymph node metastases. Good response is achieved with concurrent chemotherapy and radiation therapy. The importance of early recognition and a multidisciplinary approach are vital in ONB management.
Clinical trial identification
Editorial acknowledgement
Resources from the same session
419P - Breast arterial calcifications on mammogram and its clinical implications
Presenter: Pradeep Kumar Kistampally
Session: Poster viewing 06
420P - Predictive factors of post-operative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
Presenter: Chito Cabiling
Session: Poster viewing 06
421P - The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy
Presenter: Deniz Can Guven
Session: Poster viewing 06
422P - Molecular mechanism in prostate cancer with TP53 mutation
Presenter: Bin Hu
Session: Poster viewing 06
423P - Maintaining a national essential medicine list for cancer in Malaysia: Where do we stand?
Presenter: David Lee
Session: Poster viewing 06
424P - The Storm: Paraneoplastic leucomoid reaction - A bad prognostic factor
Presenter: Abdullah Al Mamun Khan
Session: Poster viewing 06
425P - Preliminary study: Assessment of public trust in traditional medicine and medical treatment in cancer patients in Indonesia - Study validity and reliability of the Universitas Sebelas Maret Trust and readiness assessment for cancer patients (UNS – TRAfCP35) questionnaire
Presenter: Widyanti Soewoto
Session: Poster viewing 06
426P - Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
Presenter: Alexey Rumyantsev
Session: Poster viewing 06
427P - Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?
Presenter: Gayathri Kumar
Session: Poster viewing 06
428P - Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
Presenter: PRASHANT SIROHIYA
Session: Poster viewing 06